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Going Back To Understand the Future: Socioeconomic Position and
Survival after Myocardial Infarction
Do we really need another paper on socioeconomic in-equalities in health? After all, we have known for de-
cades (or centuries, as some would say [1]) that, for most
health outcomes, the rich do better and the poor do worse
(2). After a literature search (3), I found that the rate at
which articles were being published on this topic was more
than 300 papers per month. When I recently updated the
search, the exponential increase in publications had not
abated in the slightest. We hear whispers of “enough stud-
ies, it’s time to intervene,” and yet more and more submis-
sions arrive on the desks of journal editors and reviewers.
Current research on socioeconomic disparities in
health can be grouped into 3 main areas. First, many stud-
ies are further documenting the association between socio-
economic position and health. Second, numerous studies
seek the reasons for the association. Within this domain,
some offer explanations that invoke poverty and material
conditions on the one hand and psychosocial factors, such
as control or depression, on the other (4); others examine
the role of behavioral and biological pathways that link
socioeconomic position and health (5). Other studies that
fall into this category have investigated the causes of socio-
economic inequalities throughout the course of life, per-
haps even starting in utero (6); the contribution of neigh-
borhoods and communities to disparities (7); and, of
course, the role of access and quality of medical care (8).
Third, other studies have examined interventions to reduce
income-related disparities in health outcomes; this category
has far fewer examples.
In this issue, Alter and colleagues (9) seek explanations
by using data from a cohort of almost 5000 Canadian
patients who were hospitalized after myocardial infarction
(MI). The researchers examined the association between
income and 2-year survival after MI. They focused on how
demographic factors, disease history, current risk factors,
aspects of care, and psychosocial factors contributed to the
higher mortality rate in patients with low household in-
comes ($30 000 Canadian) compared with those who
had high incomes ($60 000 Canadian). They obtained
patient data (except for smoking and family history) from
hospital discharge records, which is a better source than the
patient’s recollection or someone’s assessment of the pa-
tient’s clinical status at the time of the MI. For every pa-
tient, they had information regarding cardiovascular dis-
ease and risk factors for as many as 12 years before the
index MI.
Alter and colleagues, like others before them, found
relationships between socioeconomic position and both the
incidence of vascular disease and patient survival with vas-
cular disease (10). Of note, they found that the association
between household income and mortality rate was substan-
tially weaker after they adjusted for differences in the be-
tween-group prevalence of preexisting cardiovascular dis-
ease and cardiac risk factors (diabetes, hypertension,
hyperlipidemia, smoking, and family history of cardiovas-
cular disease). Although these observations advance the
field, they are not surprising. The strongest predictor of
outcome after MI is probably the patient’s disease status
before the index event. In fact, the subgroup analyses de-
tailed in Alter and colleagues’ Table 4 indicate that patients
with higher household incomes had an increased survival
rate only if they had a history of angina, previous MI,
revascularization, or congestive heart failure. This sub-
group finding seems to support the authors’ argument that
the association between socioeconomic status and survival
after MI mainly reflects that poorer patients have a greater
incidence of preexisting cardiovascular disease and athero-
genic risk factors, both of which could decrease survival
after MI.
How should we interpret the important role of
preevent health status in explaining worse survival rates
among poorer patients? This editorial considers 4 central
issues: the interpretation of the words “cause” and “ex-
plain”; the role of disease determinants and processes that
occur over the course of life in generation of socioeco-
nomic inequalities in health; the importance of compre-
hensive, valid measures; and between-country variations in
socioeconomic disparities.
Alter and colleagues “affirm the importance of tradi-
tional atherogenic risk factors as a major cause [emphasis
added] of disparities between income and mortality rates.”
They propose that efforts to target cardiovascular risk fac-
tors among disadvantaged patients might reduce income-
related disparities in outcome. But they also assert that
previous health status and cardiovascular risk factors form
the “central intermediary pathway” between socioeco-
nomic position and survival after MI. If previous health
status and atherogenic risk factors are on the pathway that
connects socioeconomic level with disparities in clinical
outcomes, are income-related differences in preevent car-
diovascular health status also a “cause” of the disparities?
Certainly, the relationship is causal because cardiovascular
disease status before MI drives postinfarction survival. But
what about the factors that Geoffrey Rose calls the “causes
of the causes” (11)? As in much of the work in this area,
the paper does not carefully distinguish between how so-
cioeconomic position relates to outcomes—an issue of the
intermediate mechanisms—and why income level is related
to the intermediate mechanisms that drive outcomes (11).
The answer to the “why” question requires an understand-
ing of the social forces that lead to observed differences in
disease and disease risk factors between people of different
Annals of Internal MedicineEditorial
www.annals.org 17 January 2006 Annals of Internal Medicine Volume 144 • Number 2 137
socioeconomic standing (12). In other words, even if we
can identify all the intermediate mechanisms that explain
the association, we still need to also understand why these
mechanisms are distributed differently among the rich and
poor. Presumably, the authors’ goal of reducing vascular
risk factors among the disadvantaged can only be achieved
with an understanding of the intermediate pathways and
the social forces that cause these intermediate factors to be
differently distributed in the rich and the poor.
The importance of preevent health status in correlat-
ing socioeconomic position with survival after MI is also
interesting from the perspective of disease progression.
Atherosclerotic vascular disease develops over many de-
cades, and the large window on disease status that the au-
thors provide (as many as 12 years’ worth of data) gives
much more information about accumulative disease pro-
cesses related to socioeconomic position than if they had
only measured disease severity at time of hospital dis-
charge. It would have been nice to know if poorer patients
had a longer history of cardiovascular disease or cardiac risk
factors.
Alter and colleagues also took on the shibboleths of
the effects of psychosocial factors (marital status and social
support) and medical care (quality of clinical care) on out-
comes. They examined how each contributes to explaining
the association between income and survival after MI. Nei-
ther of these influences accounted for income-related dif-
ferences in survival. Here, I am less convinced by their
findings because of the limitations in their choice of mea-
sures of psychosocial status and medical care quality. For
example, they used 2 items (whether the patients lived
alone and whether they had someone they could talk to
about personal matters) to measure social contacts and so-
cial engagement. These questions do not adequately mea-
sure the breadth of psychosocial factors that other studies
have found to be associated with cardiovascular outcomes.
Even if they used high-quality measures, they evaluated too
few variables to completely reject a role of psychosocial
factors. Another example: They used the attending physi-
cian’s specialty as a proxy for the quality of in-hospital
pharmacologic management and the number of early revas-
cularization procedures as a measure of quality of care.
Without information on the severity of the MI and the
clinical status of the patient, it is impossible to judge if
revascularization was good care or unnecessary care. Be-
cause of these doubtful choices of measurement tools, we
cannot say whether psychosocial factors and variations in
medical care contributed to socioeconomic variations in
the sample’s survival rate after MI.
Finally, there is the issue of location. Alter and col-
leagues analyzed data from patients in Canada. Although
Canada and the United States share a common border,
their citizens do not share common health destinies. For
example, if U.S. citizens died at the same rate as Canadi-
ans, the United States would have had 11% fewer deaths
than Canada in 1998, and most of these would have been
from diseases related to the heart and circulation (13). Of
even more importance, the relationship between income
inequality and health outcomes is different in the 2 coun-
tries. The effects are weaker in Canada (14, 15), and we do
not know why. Perhaps the links between income and the
more proximal determinants of health outcomes are weaker
in Canada. Perhaps universal access to health care in Can-
ada partially shields the poor from the health consequences
of poverty. The time seems ripe to compare the United
States with Canada directly; a good starting point would be
to replicate Alter and colleagues’ study in the United
States.
So, do we really need another paper on socioeconomic
inequalities in health? This latest study has added to our
knowledge, but can we assume that we can reduce socio-
economic inequalities in survival rates after MI simply by
reducing levels of preexisting cardiovascular disease and
atherogenic risk factors? To accomplish this goal, we must
integrate our knowledge of upstream social determinants
that lead to differential burdens of cardiovascular disease
and its risk factors and the downstream, proximal biologi-
cal factors that drive health outcomes (15). Building a
bridge between these 2 bodies of knowledge could provide
a way to decrease socioeconomic inequalities in survival.
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POLICY ON TRIALS
Annals will publish clinical trials only if they are registered in a public
registry. Trials that begin on or after 1 July 2005 must be registered at
or before the onset of patient enrollment. Registration of trials that
began before 1 July 2005 may be done after onset of patient enroll-
ment. Authors can obtain current information on acceptable registries
at www.ICMJE.org and can register their trials free of charge at www
.clinicaltrials.gov.
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